A decrease in L-type calcium current (I CaL ) is an important mechanism favouring atrial fibrillation (AF). Here, we aimed to identify pathogenic factors associated with I CaL downregulation.
Introduction
Atrial fibrillation (AF) is the most frequent cardiac arrhythmia and is favoured by several factors, including valve diseases, heart failure, hypertension, and ageing. 1 The pathophysiology of AF is complex and this condition is usually associated with profound functional and structural alterations of the atrial myocardium. 2 -5 At the cellular level, the arrhythmogenic substrate is characterized by a shortened action potential (AP) without plateau phase and that adapts poorly to changes in heart rate. 4 This cellular electrical remodelling is believed to contribute to the reduction of effective refractory periods (ERPs) and to favour the constitution of microwavelet re-entry. 6, 7 A major mechanism of AP shortening during AF is the reduction of the L-type calcium current (I CaL ). A decrease of 70% in I CaL has been consistently observed during AF in both human atrial myocytes and experimental models. 5, 8, 9 This current is the main depolarizing current that activates during the plateau phase of the AP. Moreover, Ca 2+ channels are the target for several neuromediators which regulate cardiac function by modulating channel phosphorylation via several protein kinases and phosphatases and, in turn, the current amplitude. In addition to its role in shaping the AP, I CaL triggers the release of calcium from the sarcoplasmic reticulum and is thus a key actor for the activation of the contraction. Indeed, its downregulation during AF is an important determinant of the depressed atrial contractility. 10 A number of studies have attempted to identify pathogenic factors underlying I CaL downregulation during AF. Both alterations in the expression level and activity of Ca 2+ channels have been described during arrhythmia. 5,11 -13 Experimentally it was demonstrated that a high beating rate, chronic atrial volume overload, or heart failure can cause the downregulation of I CaL . 8, 14, 15 Here, we examined clinical parameters associated with changes in the atrial I CaL in human patients. The possibility of obtaining samples of right atrial appendage during routine cardiac surgery permits the recording of calcium currents associated with various clinical conditions. We found that the peak I CaL varies between atrial myocytes and that this variability is related to the clinical history of the patient.
Methods

Clinical data and cardiac myocyte preparation
With approval of our Ethics Committee, specimens of right atrial appendage were obtained between 2001 and 2006 from 86 patients (32-90 years, mean 56 + 4 years) undergoing heart surgery for coronary bypass (n = 56), mitral (n = 10), or aortic (n = 20) valve repair/ replacement. As the right atrial sample is considered surgical tissue waste, no consent has to be obtained from donor. Left ventricle ejection fraction (LVEF) was measured by echocardiography or isotopic assay. All patients were in sinus rhythm during the inhospital period. However, it is possible that some of them had experienced episodes of paroxysmal or silent AF. Most of the patients were treated with b-adrenergic antagonists and angiotensin-converting enzyme-inhibitors ( Table 1) . Treatments were stopped at least 8 h before surgery. Myocytes were isolated as described previously. 16 The criterion for inclusion in the study was for patients to undergo a cardiac surgery with an extracorporeal circulation allowing to obtain a right atrial sample. The yield of live isolated myocytes and the quality of the current recording were the final criteria for inclusion.
Current measurements
Whole-cell Ca 2+ currents were recorded using the patch-clamp technique as described previously. 16 For calcium current inactivation measurement, test pulses were preceded by 2 s conditioning pulses. Activation plots were generated by dividing peak I CaL measured at a given potential by the difference between measured and reversal potential. Data on the conductance/voltage activation and inactivation curves were best fitted to a Boltzmann distribution equation:
respectively, where G represents the conductance calculated at membrane potential V, I the amplitude of I CaL at the conditioning potential V, V 1/2 the potential at which half of the channels are activated or inactivated, and k the slope factor. Concentration-response curves were fitted as follows:
where E is the percentage change in I Ca , E max is the maximal response induced by the drug, and [D] is the concentration of isoproterenol (ISO) tested. 
Solutions and reagents
Statistical analysis
The reproducibility of current measurements in the various cells isolated from a given tissue sample was assessed using the BlandAltman method. 17 A plot of the difference between measures against their mean was constructed and the bias (mean difference + SD) was calculated. I CaL density was compared according to gender, LV dysfunction, and the type of cardiopathy by Wilcoxon's rank sum test for non-normally distributed data. The clinical variables were defined a priori as the main variable known to be associated with a risk of AF. A univariable analysis and a stepwise multivariate linear regression analysis with age, gender, LV dysfunction, and cardiopathy were performed to identify factors associated with I CaL variability using a probability value of P , 0.05. The generated model was validated internally with the use of bootstrap re-sampling method according to the 'boot' package [Bootstrap R (S-Plus) Functions (Canty); R package version 1. Calcium current and human atria Vienna, Austria; ISBN 3-900051-07-0, URL http://www.R-project.org). We generated 9999 same-sized duplicates for the original database and analysed distribution for each selected variable parameter. Ninety-five per cent confidence intervals (bias corrected, accelerated) were then estimated for each parameter. No sample size calculation was performed for this observational study. The study was stopped when we considered to have enough data to perform analysis on the basis of the other studies of the literature conducted on human atrial myocytes. Tests were two-sided, and the significance level was fixed at 5%. All results are shown as means + SD.
Results
Marked variability of calcium current density between atrial myocytes
A calcium current could be recorded during 300 ms step depolarization in the 172 myocytes studied. However, there was an important scattering of its peak density ranging from 0.1 to 9.0 pA/pF. Membrane capacitance, an indicator of the myocyte size, was also dispersed, ranging from 40 to 150 pF, suggesting different populations of atrial myocytes. However, there was only a weak correlation between peak current amplitude or current density and membrane capacitance, suggesting that the number of functional channels per membrane surface was rather variable ( Figure 1B and C ). In order to examine whether peak I CaL heterogeneity reflected changes in current properties, we arbitrarily defined a group A of currents with a density ,2.5 pA/pF and a group B of currents with a density .2.5 pA/pF. In both groups, the threshold of current activation was around 240 mV, I CaL peaked at 0 mV, and its apparent reversal potential was measured at 100 mV ( Figure 2A) . The voltage-dependent activation and steady-state inactivation relationships of I CaL did not differ between the two groups ( Figure 2B and C ). These results indicated that although I CaL density varied between atrial samples, this was not due to changes in current properties or to different populations of myocytes.
Clinical parameters associated with variation of calcium current density
We next examined whether clinical parameters were associated with changes in I CaL . As only a few myocytes could be studied per sample (from 2 to 7), we first verified that the density of I CaL recorded in myocytes from the same sample was homogeneous. This question was addressed by testing the similarity between two I CaL values measured from two distinct myocytes of the same sample. 17 Comparison of the difference between the means of I CaL measurements ( Figure 3) showed that measures were in good agreement. Figure 3 ). This statistical analysis was repeated with all cell pairs and yielded similar results. These data indicated that peak I CaL density was relatively homogeneous for a given sample, especially when the current was of small density. Thus, even if only a few current measurements could be performed per sample, they could be considered representative of the whole sample. Univariable analysis revealed two conditions associated with small I CaL density. First, patients suffering from mitral valve disease (MVD) had a smaller I CaL density compared with other patients [0.99 + 0.62 pA/pF (n = 10 patients) vs. 3.27 + 2.01 pA/ pF (n = 76 patients), P , 0.0007]. Membrane capacitance in the former group was also increased (92 + 28 vs. 69 + 25 pF; P , 0.001). Secondly, a small I CaL value was also observed in patients with a decreased LV function (LVEF , 45%) and suffering from ischaemic heart disease or aortic valve disease: 1.78 + 0.86 (LVEF , 45%, n = 29) vs. 3.63 + 2.18 (LVEF . 45%, n = 57) (P , 0.0001) (Figure 4) . Membrane capacitance was also increased in this group of patients (99 + 31 vs. 69 + 24 pF; P , 0.001). Multivariable linear regression analysis including age, gender, MVD, and LV function confirmed that MVD (regression coefficient 22.46 + 0.59, P , 0.0001) and decreased LV (regression coefficient 21.80 + 0.39, P , 0.001) were both independently associated with the downregulation of I CaL . The bootstrap statistics (mean, 95% CI) of the regression coefficient were MVD 22. 
Calcium current and human atria
Enhanced response of small calcium currents to a b-adrenergic agonist
To examine whether I CaL heterogeneity could be due to variations in current phosphorylation, we studied the effect of the b-adrenergic agent, ISO (1 mM), on I CaL . There was an important variation in the response of I CaL to ISO, varying from no effect to a marked stimulatory effect ( Figure 5 ). Plotting the percentage of the ISO effect on I CaL against current density showed that small currents were more sensitive to ISO (r = 0.51; P , 0.0001) ( Figure 5 ). The concentration-dependent effect of ISO on I CaL was compared between a group of myocytes obtained from patients with MVD or with a low LV ejection fraction (n = 5) and patients with coronary artery disease (CAD) and normal LV function (n = 5). At each concentration tested, the response of I CaL to ISO was much higher in the group of patients with a small I CaL value without difference in the EC 50 (29.6 + 7.8 vs. 29.2 + 10.5 nM for the CAD group) ( Figure 5) . In both groups, the phosphodisterase inhibitor IBMX increased I CaL , but this effect was much more pronounced in myocytes from patients with MVD or low LV ejection fraction (n = 7 myocytes from three atria) than in those from CAD patients (n = 6 myocytes, from three atria) (P , 0.001) ( Figure 5 ).
Discussion
A reduction in the L-type calcium current has been consistently reported during AF and is believed to constitute an important arrhythmogenic factor through the shortening of AP duration and refractory periods. 7 In the present study, we found that a marked reduction of I CaL is already observed in atrial myocytes from patients known to be the most susceptible to develop AF. Moreover, the variation of current is due, for a large part, to changes in b-adrenergic effects on I CaL . The variability of I CaL between human atrial samples cannot be explained by alterations in current biophysical properties as indicated by the absence of variation in the voltage-gating properties of I CaL . Different populations of atrial myocytes are unlikely to explain current changes given the lack of correlation between cell size and the peak or density of I CaL . It rather suggests that the density of functional calcium channels varies between samples. Transcriptional and post-transcriptional regulation of calcium channels have been described in the atrial myocardium. 5,11 -13 During AF, myocytes contain less L-type Ca 2+ channels. 12, 18 Another important mechanism underlying I CaL downregulation during AF is the decrease in channel activity.
11
A high sensitivity of I CaL to b-adrenergic agonists has been reported during AF, suggesting that basal phosphorylation of calcium channels is reduced. 5 Here, we also found that the smallest I CaL value have the greatest response to b-adrenergic agonist. In cardiac myocytes, basal phosphorylation of calcium channels is necessary to maintain normal channel function. 19, 20 It is thus plausible that in diseased atria, a number of channels become silent in basal conditions but can be recruited upon b-adrenergic stimulation.
Phosphodiesterases are important determinants of cAMP metabolism, notably in atrial myocytes. 21 Our finding that small I CaL values are more sensitive to phosphodiesterase inhibition than control currents provides another argument in favour of the existence of variations in phosphorylation of calcium channels. Several phosphatases are also involved in the regulation of Ca 2+ channels and their activity is increased during AF, most likely contributing to the downregulation of I CaL . 22 We found that I CaL variability is related to the clinical history of the patient. Patients with MVD or in chronic heart failure exhibited a marked downregulation of I CaL as observed during AF. This finding is in good agreement with a transcriptomic study showing a reduction of CACNAIC transcript during both AF and MVD. 13 During chronic atrial dilatation in human, AP becomes shorter and I CaL is downregulated. 9 Furthermore, it has been demonstrated that a moderate volume overload of the atrium is sufficient to cause I CaL reduction. 15 Collectively, these studies indicate that changes in atrial haemodynamic conditions play an important role in the electrical remodelling of the atrial myocardium. 23 MVDs or HF are most often associated with some degree of haemodynamic overload of the right atrium as the consequence of the increase in post-capillary pulmonary pressure. In these patients, the increase in myocyte size, i.e. larger membrane capacitance, supports the possibility of hypertrophic myocardial remodelling in response to right atrial haemodynamic overload. Several neuromediators or peptides could also be involved in the altered channel activity during HF or MVDs including endothelin, angiotensin-II, or atrial natriuretic peptide (ANP). 24 Of note, in some patients of the present study, plasma ANP was increased (.100 pg/mL) in patients with small I CaL value. In human atrial myocytes, ANP reduces I CaL by stimulating cGMP-dependent phosphodiesterase. 16 It has been shown that in dilated atria of rats in HF, the downregulation of I CaL is due to an abnormal intracellular accumulation of cGMP and a subsequent abnormal activation of PDE. 14 The redox state could be also altered in atrial myocytes from patients with MVD or in HF. 25 Interestingly, glutathione, an important modulator of cellular redox state, is decreased during AF 26 and its level determines the amplitude of I CaL in human atrial myocyte directly, by changing the nirosylation of calcium channels, 26 or indirectly, via the modulation of kinase/ phosphatases. 27 During AF, the downregulation of I CaL is believed to be a major determinant of the shortening of ERP. Unlike in AF, ERP was not found to be reduced in dilated atria or during CHF. 28 -30 Thus, the role of I CaL downregulation in the vulnerability to AF in these clinical settings is not clear. One explanation could be that during atrial haemodynamic overload, the right appendage undergoes an early and severe electrical remodelling compared with the rest of the atria which contributes importantly to the global refractory period. Indeed, trabeculae of dilated human right atrial appendage exhibit a short ERP. 9 The lack of change of refractory periods might be explained by a paralleled decrease in repolarizing currents that can mask the reduction in I CaL . For instance, the delayed rectifier current, I kr , is reduced in CHF but not in the rapid pacing dog models. 8 Atrial stretch which can alter repolarizing currents might be particularly pronounced during chronic atrial haemodynamic overload. 31, 32 Finally, I CaL downregulation might be a protective mechanism against calcium overload and activation of calciumdependent signalling cascades known to be responsible for phenotypic changes of the atrial myocardium. 33 
Limitations of the study
Only myocytes from right atrial appendage were studied while the electrical remodelling of the atrial myocardium may not be homogeneous between the different atrial areas. However, similar electrical remodelling was observed between left and right atria. 5 Secondly, although a relationship between I CaL downregulation and alterations of the electrical properties of atrial myocytes is well established, 7 we have no direct information on consequences of the alteration of I CaL on AP duration, ERP, and on atrial vulnerability to AF. We did not find a relation between post-operative AF and small I CaL in keeping with a study showing that changes in ionic currents of human atrial myocytes do not predict the occurrence of AF during the post-operative period. 34 Also, it was not possible to perform a longitudinal follow-up of patients in order to study the occurrence of AF because, fortunately, the cardiopathies of these patients have been cured. Nevertheless, it seems reasonable to conclude that an important determinant of normal atrial excitability is altered before AF.
Conclusion
Our observation that patients in sinus rhythm with an increased risk of AF have a small I CaL as during AF suggests that this alteration precedes the arrhythmia. This is reminiscent of observations that fibrosis, myocyte apoptosis, or alteration of gap junctions can be observed before AF. 2, 35, 36 This is also in agreement with the observation of a similar transcriptomic ionic channel profile between the atria of patients in AF or with valve diseases in sinus rhythm. 13 Thus, besides rapid beating, several pathogenic factors could favour the development of the AF substrate. Their identification is of major importance and to define new therapeutic strategies for the prevention of AF.
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